Science Explorer Interactive view Map
Company · Gaithersburg · United States

MaxCyte (United States)

maxcyte.comROR OpenAlex
Research works
34
▲ 11% vs 2013–17
Citations
637
18.8 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: MaxCyte (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 12.57× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 8.81× its world share, 0 worksImmunology and Micro…Engineering: 0.11× its world share, 0 worksEngineeringMedicine: 1.03× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 0.93× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 12.6×. Every wedge is a field page.

Which keywords describe research at MaxCyte (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Gene Therapy, Immunotherapy, Lymphoma, Leukemia, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Cancer Immunotherapy8▲ 158×3 topics
  2. Gene Therapy7▲ 78×4 topics
  3. Immunotherapy6▲ 27×5 topics
  4. Lymphoma6▲ 119×3 topics
  5. Leukemia6▲ 259×2 topics
  6. Tumor Regression6▲ 193×2 topics
  7. CAR T Cells6▲ 378×1 topic
  8. Chimeric Antigen Receptor6▲ 378×1 topic
  9. Genome Engineering4▲ 216×1 topic
  10. RNA-Guided4▲ 216×1 topic
  11. Genomic Integration4▲ 110×2 topics
  12. AAV4▲ 168×1 topic
  13. Viral Vectors4▲ 168×1 topic
  14. Immunity3▲ 23×3 topics
  15. Innate Immunity2▲ 18×2 topics
  16. Antigen Presentation2▲ 55×1 topic
  17. Dendritic Cells2▲ 48×1 topic
  18. Glycosylation2▲ 24×2 topics
  19. Electroporation2▲ 231×1 topic
  20. Irreversible Electroporation2▲ 231×1 topic
  21. RNA Interference2▲ 39×1 topic
  22. siRNA Delivery2▲ 58×1 topic
  23. Biopharmaceutical Production1▲ 54×2 topics
  24. Cell Culture1▲ 36×2 topics
  25. Monoclonal Antibody1▲ 59×2 topics
  26. Mammalian Cells1▲ 96×1 topic
  27. NK Cell Recognition1▲ 38×1 topic
  28. Natural Killer Cells1▲ 38×1 topic
  29. Recombinant Protein1▲ 96×1 topic
  30. Plant Molecular Farming1▲ 149×1 topic
  31. Recombinant Proteins1▲ 68×1 topic
  32. Autoimmunity1▲ 15×2 topics
  33. Rituximab1▲ 19×2 topics

Which research topics does MaxCyte (United States) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, Virus-based gene therapy research, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.

CRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksVirus-based gene therapy research: 1 fractional worksCAR-T cell therapy research: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksTransgenic Plants and Ap…0Transgenic Plants and Applications: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksWnt/β-catenin signaling in development and cancer: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksGenomic variations and chromosomal abnormalities: 0 fractional works
Molecular BiologyGeneticsOncologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 CAR-T cell therapy research Oncology 1 works
  4. 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Transgenic Plants and Applications Biotechnology 0 works
  7. 7 Cancer-related Molecular Pathways Oncology 0 works
  8. 8 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
  9. 9 T-cell and B-cell Immunology Immunology 0 works
  10. 10 Genomic variations and chromosomal abnormalities Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.5%not open64.5%

World: 28% of research is openly available.

with international co-authors19.8%domestic only80.2%

World: 19% is written across borders.

How has MaxCyte (United States)'s research output changed?

Output in 2018–2022 was 11% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.